Today: 16 April 2026
Subscribe
Browse Category

LSE:S32.L 6 March 2026

South32’s 90% Base-Metals Bet Takes Shape as CEO Graham Kerr Pushes North America Pivot

South32’s 90% Base-Metals Bet Takes Shape as CEO Graham Kerr Pushes North America Pivot

South32 expects about 90% of its production to be in base metals within 18 months, outgoing CEO Graham Kerr told Financial Mail. Stephen Pearce became chair on March 1, and Matthew Daley is set to succeed Kerr as CEO later this year. The company posted first-half underlying earnings of $435 million, beating estimates. South32 will place its Mozal aluminium smelter in Mozambique into care and maintenance by March.
6 March 2026
··

Stock Market Today

  • InterContinental Hotels to Cancel 40,000 Shares After Buyback
    April 16, 2026, 2:31 AM EDT. InterContinental Hotels Group (IHG) bought back 40,000 ordinary shares on April 15, 2026, at an average price of $141.98 each. The purchase was executed through Goldman Sachs International, following shareholder approval in May 2025 and company instructions from February 17, 2026. IHG plans to cancel these repurchased shares, reducing the total shares outstanding. Post-transaction, the company has 150,184,953 ordinary shares issued, excluding 5,431,782 held in treasury. The buyback reflects IHG's ongoing capital management strategy to enhance shareholder value through share cancellation.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 16.04.2026

16 April 2026
LIVEMarkets rolling coverageStarted: April 16, 2026, 12:00 AM EDTUpdated: April 16, 2026, 2:31 AM EDT InterContinental Hotels to Cancel 40,000 Shares After Buyback April 16, 2026, 2:31 AM EDT. InterContinental Hotels Group (IHG) bought back 40,000 ordinary shares on April 15, 2026, at an average price of $141.98 each. The purchase was executed through Goldman Sachs International, following shareholder approval in May 2025 and company instructions from February 17, 2026. IHG plans to cancel these repurchased shares, reducing the total shares outstanding. Post-transaction, the company has 150,184,953 ordinary shares issued, excluding 5,431,782 held in treasury. The buyback reflects IHG's ongoing
Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Go toTop